La Jolla Pharmaceutical Co.

Formerly NASDAQ: LJPC
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 10 pages La Jolla Pharmaceutical Company Incorporated Under the Laws of the State of Delaware By-Laws
12/34/56
EX-3.1
from 8-K 2 pages Amended and Restated Certificate of Incorporation of La Jolla Pharmaceutical Company * * * * * * * *
12/34/56
EX-3.3
from 8-K12B 2 pages [Reverse of Certificate] La Jolla Pharmaceutical Company
12/34/56
EX-3.2
from 8-K12B 11 pages Bylaws of La Jolla Pharmaceutical Company
12/34/56
EX-3.1
from 8-K12B 19 pages Amended and Restated Certificate of Incorporation of La Jolla Pharmaceutical Company
12/34/56
EX-3
from SC 13D 2 pages June 19, 2020 • the La Jolla Board of Directors Has Approved the Transaction and Authorized Our Execution of the Merger Agreement, Subject to Your Termination of the Melinta Merger Agreement. • Our Proposal Is Not Subject to Any Financing Contingencies. We Stand Ready to Fund 100% of the Purchase Price With Cash on Hand (As of March 31, 2020, La Jolla Had $77.2 Million of Cash and No Debt). • in an Effort to Put the Parties in a Position to Move Quickly, We Have Agreed to Use the Form of the Melinta Merger Agreement. We Have Enclosed a Redline of the Merger Agreement, Marked to Show Changes From the Melinta Merger Agreement
12/34/56
EX-3.1
from 8-K 11 pages La Jolla Pharmaceutical Company (The “Corporation”) Bylaws
12/34/56
EX-3.4
from 8-A12B/A 11 pages La Jolla Pharmaceutical Company (The “Corporation”) Bylaws
12/34/56
EX-3.3
from 8-A12B/A 2 pages Certificate of Amendment of Articles of Incorporation of La Jolla Pharmaceutical Company a California Corporation Pursuant to Section 910 of the California General Corporation Law
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment of Articles of Incorporation of La Jolla Pharmaceutical Company a California Corporation Pursuant to Section 910 of the California General Corporation Law
12/34/56
EX-3.2
from 8-K 11 pages La Jolla Pharmaceutical Company (The “Corporation”) Bylaws Section 1 - Offices
12/34/56
EX-3.1
from 8-K 22 pages Articles of Incorporation of LJPC Merger Sub, Inc
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Elimination of Series C-11 Convertible Preferred Stock; Series C-21 Convertible Preferred Stock; Series D-11 Convertible Preferred Stock and Series D-21 Convertible Preferred Stock of La Jolla Pharmaceutical Company (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Restated Certificate of Incorporation of La Jolla Pharmaceutical Company
12/34/56
EX-3.1
from 8-K 29 pages Certificate of Designations, Preferences and Rights of Series C-12 Convertible Preferred Stock, Series C-22 Convertible Preferred Stock, Series D-12 Convertible Preferred Stock and Series D-22 Convertible Preferred Stock of La Jolla Pharmaceutical Company Pursuant to Section 151 of the Delaware General Corporation Law I. Designation and Amount
12/34/56
EX-3.2
from 8-K ~5 pages Amended and Restated Bylaws for the Regulation of La Jolla Pharmaceutical Company, a Delaware Corporation
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of La Jolla Pharmaceutical Company, as Amended
12/34/56
EX-3.2
from 8-K 16 pages Certificate of Designations, Preferences and Rights of Series E Convertible Preferred Stock of La Jolla Pharmaceutical Company (Pursuant to Section 151 of the Delaware General Corporation Law) I. Designation and Amount
12/34/56
EX-3.1
from 8-K 28 pages Certificate of Designations, Preferences and Rights of Series C-11 Convertible Preferred Stock, Series C-21 Convertible Preferred Stock, Series D-11 Convertible Preferred Stock and Series D-21 Convertible Preferred Stock of La Jolla Pharmaceutical Company Pursuant to Section 151 of the Delaware General Corporation Law I. Designation and Amount
12/34/56
EX-3.1
from 8-K ~20 pages Certificate of Designations, Preferences and Rights of Series C-1 Convertible Preferred Stock, Series C-2 Convertible Preferred Stock, Series D-1 Convertible Preferred Stock and Series D-2 Convertible Preferred Stock of La Jolla Pharmaceutical Company (Pursuant to Section 151 of the Delaware General Corporation Law) I. Designation and Amount
12/34/56